Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton.
Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton.
Am J Med. 2022 Oct;135(10):1263-1266. doi: 10.1016/j.amjmed.2022.05.015. Epub 2022 May 28.
Alcoholic cirrhosis is an advanced form of alcohol-related liver disease. In the United States, between 2010 and 2016, alcohol-related liver disease was the primary cause of nearly 1 in 3 liver transplants, surpassing hepatitis C.
We utilized the US Centers for Disease Control and Prevention's Wide-ranging Online Data for Epidemiologic Research database to compare trends in mortality from alcoholic cirrhosis in the United States in 1999 and 2019. We defined mortality from alcoholic cirrhosis as International Classification of Diseases code K70.3 (alcoholic cirrhosis of liver). We calculated mortality rates and mortality rate ratios (MRRs) per 100,000 from alcoholic cirrhosis in 10-year age groups from 25 to 85+ as measures of effect and 95% confidence intervals to test for significance.
In 1999, there were 6007 deaths from alcoholic cirrhosis among 180,408,769 aged 25-85+ years, yielding a mortality rate of 3.3 per 100,000. In 2019, there were 23,780 deaths from alcoholic cirrhosis among 224,981,167 aged 25-85+ years, yielding a mortality rate of 10.6 per 100,000. The overall MRR of 3.2 was statistically significant. (P < .001), and was apparent in each 10-year age group.
These alarming trends in mortality from alcoholic cirrhosis in the United States contribute to the formulation of many hypotheses. These require testing in analytic studies designed a priori to do so. Meanwhile, clinical and public health efforts are necessary to curb the epidemics of heavy alcohol consumption and overweight and obesity in the United States that may be contributing to these alarming trends.
酒精性肝硬化是一种晚期的酒精相关性肝病。在美国,2010 年至 2016 年间,酒精相关性肝病是近三分之一肝移植的主要原因,超过了丙型肝炎。
我们利用美国疾病控制与预防中心的广泛在线流行病学研究数据库,比较了 1999 年和 2019 年美国酒精性肝硬化死亡率的趋势。我们将酒精性肝硬化的死亡率定义为国际疾病分类第 K70.3 编码(酒精性肝硬化)。我们计算了 25 岁至 85 岁以上人群中每 100000 人因酒精性肝硬化死亡的死亡率和死亡率比值(MRR),作为衡量效果的指标,并计算了 95%置信区间以检验其显著性。
1999 年,年龄在 25-85 岁以上的 180408769 人中,有 6007 人死于酒精性肝硬化,死亡率为 3.3/100000。2019 年,年龄在 25-85 岁以上的 224981167 人中,有 23780 人死于酒精性肝硬化,死亡率为 10.6/100000。整体 MRR 为 3.2,具有统计学意义(P <.001),且在每个 10 岁年龄组中均如此。
美国酒精性肝硬化死亡率的这些惊人趋势导致了许多假说的提出。这些假说需要在预先设计的分析研究中进行检验。同时,需要采取临床和公共卫生措施,以遏制美国的酗酒、超重和肥胖流行,这些可能是导致这些惊人趋势的原因。